Psilocybin Stock Picks: An Investor's Shroom Trip Experience
Shrooms are suddenly everywhere — Oregon just voted to legalize magic mushrooms, and speculators quickly rushed to compare the psychedelic drug to cannabis, another psychoactive substance that's been pushing along the path to legalization. We spoke to a couple of members of the Dumb Money community about their shrooms experience, and some stock picks that are worth looking into considering the news.
COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States.It develops COMP360, a psilocybin formulation, which is in Phase IIb clinical trial to treat patients with treatment-resistant depression. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020.COMPASS Pathways plc was incorporated in 2020 and is based in Cheshire, the United Kingdom. (From: StockAnalysis.com)